'What's wrong with having lots of patents?' Federal appeals judge sides with AbbVie in Humira case - Endpoints News

A federal appeals court ruled in AbbVie’s favor on Monday, upholding an Illinois court’s decision to dismiss allegations that the pharma giant created an unlawful “patent thicket” around its blockbuster drug Humira. Since its first approval in rheumatoid arth…

A fed­er­al ap­peals court ruled in Ab­b­Vie’s fa­vor on Mon­day, up­hold­ing an Illi­nois court’s de­ci­sion to dis­miss al­le­ga­tions that the phar­ma gi­ant cre­at­ed an un­law­ful “patent thick­… [+2661 chars]

full article...